Growth Metrics

Eli Lilly (LLY) Inventory Average (2016 - 2025)

Eli Lilly (LLY) has disclosed Inventory Average for 17 consecutive years, with $13.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 72.27% year-over-year to $13.0 billion, compared with a TTM value of $13.0 billion through Dec 2025, up 72.27%, and an annual FY2025 reading of $10.7 billion, up 59.66% over the prior year.
  • Inventory Average was $13.0 billion for Q4 2025 at Eli Lilly, up from $11.6 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $13.0 billion in Q4 2025 and bottomed at $3.7 billion in Q2 2021.
  • Average Inventory Average over 5 years is $6.0 billion, with a median of $4.8 billion recorded in 2023.
  • The sharpest move saw Inventory Average fell 0.02% in 2022, then skyrocketed 72.27% in 2025.
  • Year by year, Inventory Average stood at $3.9 billion in 2021, then rose by 4.46% to $4.1 billion in 2022, then skyrocketed by 31.12% to $5.3 billion in 2023, then skyrocketed by 40.98% to $7.5 billion in 2024, then soared by 72.27% to $13.0 billion in 2025.
  • Business Quant data shows Inventory Average for LLY at $13.0 billion in Q4 2025, $11.6 billion in Q3 2025, and $10.2 billion in Q2 2025.